Idarucizumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Idarucizumab. Educational only — not medical advice.
Labeled uses
PRAXBIND is indicated in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding
Source: FDA labeling via NIH DailyMed (set c7400f8a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.